SCHEMBL783191

SCHEMBL783191

C=C1CC(=O)OC(C)(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5976 0.82 TSHR (0.36)
Iodide SCHEMBL588864 0.79 TSHR (0.35)
Butane SCHEMBL379581 0.73 PTPN1 (0.40)
SCHEMBL17072788 0.73 PTPN1 (0.33)
SCHEMBL18835801 0.71
SCHEMBL14021462 0.71
SCHEMBL9678981 0.71 TSHR (0.42)
SCHEMBL14224446 0.70
SCHEMBL12094443 0.68
SCHEMBL18825550 0.68 GLA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399343-A1 PROCESS OF MAKING CFTR MODULATORS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2023-12-14 US disclosed
US-20230142285-A1 SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
WO-2021257754-A1 SMALL MOLECULE VE-PTP INHIBITORS RIPKA, AMY (US) 2021-12-23 WO disclosed
WO-2017211666-A1 5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS GALAPAGOS NV (BE) 2017-12-14 WO disclosed
US-9579390-B2 Compounds and methods for producing a conjugate REDWOOD BIOSCIENCE, INC. (US) 2017-02-28 US disclosed
US-20170049907-A1 HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE CATALENT PHARMA SOLUTIONS, LLC 2017-02-23 US disclosed
US-20170008927-A1 ARTIFICIAL CATALYST SYSTEM SUBSTITUTABLE FOR IN VIVO ACYLATION FUNCTION THE UNIVERSITY OF TOKYO (JP) 2017-01-12 US disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-9340644-B2 Self-sensitive polymerizable liquid resin and use thereof ETERNAL MATERIALS CO., LTD. (TW) 2016-05-17 US disclosed
WO-2016033397-A1 LUBRICATING COMPOSITION WITH SEALS COMPATIBILITY THE LUBRIZOL CORPORATION (US) 2016-03-03 WO disclosed
US-20160038602-A1 Compounds and Methods for Producing a Conjugate REDWOOD BIOSCIENCE, INC. 2016-02-11 US disclosed
US-20150368264-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS GILEAD SCIENCES, INC. 2015-12-24 US disclosed
WO-2015144001-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS 南京明德新药研发股份有限公司 2015-10-01 WO disclosed
EP-2799437-A1 QUINOLINE AND CINNOLINE COMPOUNDS AND USE THEREOF Shenyang Pharmaceutical University (CN) 2014-11-05 EP disclosed
US-20130296485-A1 SELF-SENSITIVE POLYMERIZABLE LIQUID RESIN AND USE THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2013-11-07 US disclosed
EP-2285845-B1 LOW OUTGASSING PHOTORESIST COMPOSITIONS IBM (US) 2013-09-04 EP disclosed
WO-2013097280-A1 QUINOLINE AND CINNOLINE COMPOUNDS AND USE THEREOF 沈阳药科大学 (CN) 2013-07-04 WO disclosed
US-20120070413-A1 METHOD OF TREATING CANCER WITH SUBSTITUTED AMIDE DERIVATIVES KIM TAE-SEONG (US) 2012-03-22 US disclosed
WO-2011061214-A1 NOVEL HETEROCYCLIC ACRYLAMIDES AND THEIR USE AS PHARMACEUTICALS FAB PHARMA SAS (FR) 2011-05-26 WO disclosed